Expired contract

Prosigna Kits

Details

Supplier(s)
VERACYTE
Value
£204,000
Duration
2 years
Topic
Medical kits
Published
13 January 2022

Tender description

Breast cancer prognostic tests are genomic tests which are used to determine a woman's risk of hormone receptor breast cancer recurrence as well as how likely she is to benefit from chemotherapy after breast cancer surgery and/or extended endocrine treatm

Timeline

  1. Completed: Award date20 December 2021
  2. Completed: Award published13 January 2022
    Current notice
  3. Completed: Contract expiry date19 December 2023

About the buyer

The Royal Marsden NHS Foundation Trusts runs a cancer hospital with sites in Chelsea and Sutton, and buys as an NHS foundation trust. Contracts have been called off from framework agreements, including one for medical gas. Its green plan asks suppliers to help embed net zero ambitions across its supply chain.

Over the past 5 years, most of The Royal Marsden NHS Foundation Trusts's contract awards have been in medical equipment and pharmaceuticals, repair and maintenance and health and social work.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?

This one's been awarded. Find the next before it's published.

Get a free pre-tender lead
Save this contract

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.